Since 2005, UB has invested enormous financial, intellectual and administrative resources in a comprehensive strategic initiative, called UB 2020, the most comprehensive strategic planning effort in the history of the university. UB 2020 involved the formulation and implementation of an institutional academic plan that has resulted in a major investment in the research mission of the university, particularly in clinical and translational research.
A series of eight cross disciplinary strategic strengths, which represent areas of scholarly strength for UB faculty, serve as an infrastructure for bringing together groups of researchers across traditional research disciplines.
Three Strategic Strengths have a major impact on clinical and translational research and are well integrated with the Buffalo CTRC:
- Health & Wellness Across the Lifespan. At the core of this strength is the concept of the Western New York community as a “living laboratory” for the development and testing of new interventions and the measurement of their impact on disease, health and wellness of the region.
- Molecular Recognition in Biological Systems and Bioinformatics. This strategic strength is dedicated to understanding the fundamental biology and molecular nature of disease by using small molecules, molecular structures and pharmacodynamic approaches.
- Civic Engagement & Public Policy. This strength will facilitate research that addresses social and policy challenges and persistent social inequalities. Our community engagement activities interface with multiple initiatives in this strategic strength.